Influenza A virus A/South Australia/34/2019 IVR-197 (H3N2) antigen (formaldehyde inactivated)

DB15621ApprovedWithdrawnVaccines

Influenza A virus A/South Australia/34/2019 IVR-197 (H3N2) antigen (formaldehyde inactivated) is an inactivated influenza virus used in seasonal influenza vaccines. A seasonally-specific component of the influenza vaccine.

First approval: United States, 2019

Resolves to

Compound

UNII9G0XU62HKP

Clinical / RWD

RxNorm2280296

What you can answer from here — as of September 01, 2026

19Clinical trialsPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

1ContraindicationEach with its own population and attribute set

10Marketed productsAcross 4 countries and 5 labellers

1+ReferenceStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Influenza A virus A/South Australia/34/2019 IVR-197 (H3N2) antigen (formaldehyde inactivated), and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account